Technician Quality Control - Bioassay (m/w/d) at AGC Biologics

Heidelberg, Baden-Württemberg, Germany

AGC Biologics Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
NoVisa
Biopharmaceuticals, BiotechnologyIndustries

Requirements

  • Successful training (e.g., CTA, BTA, Biology Laboratory Assistant or equivalent) or Bachelor's degree, ideally with 2+ years of professional experience in an industrial environment
  • Very good practical and technical understanding of methodological issues
  • Knowledge in protein analytics
  • Professional experience in a GMP-regulated laboratory is advantageous
  • Teamwork ability, flexibility, and very good organizational skills
  • Good English skills
  • Confident handling of MS Office
  • Valid residence and work permit

Responsibilities

  • Analysis of biopharmaceuticals using various analytical techniques: Ph. Eur. methods (e.g., visual inspection, pH, endotoxins), qPCR, spectroscopic protein and activity determination (e.g., ELISA, SDS-PAGE, Western Blot)
  • Execution and documentation of analyses in a GMP environment
  • Support for relevant equipment qualifications
  • Sample organization and logistics under GMP
  • Bioanalytics for process support USP and DSP
  • Support for relevant quality documents such as deviation reports, CAPAs, and change requests
  • Experimental execution of method validations

Skills

GMP
qPCR
ELISA
SDS-PAGE
Western Blot
pH
Endotoxine
Proteinanalytik
MS Office

AGC Biologics

Contract development and manufacturing for biopharmaceuticals

About AGC Biologics

AGC Biologics specializes in the development and manufacturing of therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells for the biopharmaceutical industry. The company provides end-to-end solutions, assisting clients from the initial development stages to full-scale production. Their services are particularly focused on fast-tracking projects for orphan drugs and rare diseases, which often require quicker timelines. AGC Biologics operates a network of advanced facilities across the U.S., Europe, and Asia, all adhering to strict quality regulations known as current Good Manufacturing Practices (cGMP). What sets AGC Biologics apart from competitors is its commitment to continuous innovation and its recent expansion to enhance capabilities in cell and gene therapy. The company's goal is to support biopharmaceutical companies in bringing new treatments to market efficiently and effectively.

Bothell, WashingtonHeadquarters
2001Year Founded
$613MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Risks

Restructuring and layoffs in Colorado indicate potential financial instability.
Leadership changes may disrupt ongoing projects and affect client trust.
Significant investment in Japan could strain financial resources and divert focus.

Differentiation

AGC Biologics specializes in therapeutic proteins, plasmid DNA, and viral vectors.
The company offers fast-track project capabilities for orphan drugs and rare diseases.
AGC Biologics operates globally with facilities in the U.S., Europe, and Asia.

Upsides

Increased demand for plasmid DNA boosts AGC's gene therapy and vaccine services.
Partnership with BioConnection enhances biodrug development capabilities, attracting more clients.
Expansion in Yokohama aligns with growing mRNA and cell therapy demand.

Land your dream remote job 3x faster with AI